Medications for Treating Low Back Pain in Adults. Evidence for the Use of Paracetamol, Opioids, Nonsteroidal Anti-inflammatories, Muscle Relaxants, Antibiotics, and Antidepressants: An Overview for Musculoskeletal Clinicians
- PMID: 35584029
- DOI: 10.2519/jospt.2022.10788
Medications for Treating Low Back Pain in Adults. Evidence for the Use of Paracetamol, Opioids, Nonsteroidal Anti-inflammatories, Muscle Relaxants, Antibiotics, and Antidepressants: An Overview for Musculoskeletal Clinicians
Abstract
Background: Because pharmacological therapies may play an important role in managing musculoskeletal pain, the appropriate use of medicines for common conditions like low back pain (LBP) is critical. New evidence on the effects and safety of paracetamol, nonsteroidal anti-inflammatory drugs (NSAIDs), opioid analgesics, muscle relaxants, antibiotics, and antidepressants for LBP warrants an updated overview for musculoskeletal clinicians on this topic.
Clinical question: How effective and safe are paracetamol, NSAIDs, opioid analgesics, muscle relaxants, antibiotics, and antidepressants compared with placebo for treating LBP?
Key results: For acute LBP (<12 weeks), muscle relaxants and NSAIDs may be superior to placebo for reducing pain, but the effects of opioids, antibiotics, and antidepressants are unknown. Paracetamol provides no additional benefit for acute LBP. For chronic LBP (>12 weeks), NSAIDs, antidepressants, and opioids may be superior to placebo for reducing pain, but opioids have an established profile of harms. Antibiotics may also reduce pain for people with chronic LBP with Modic type 1 changes, although the risks may outweigh their benefits. The effects of paracetamol and muscle relaxants for chronic LBP were unclear.
Clinical application: NSAIDs may have a role in managing acute and chronic LBP, with cautious use in people who may be at greater risk of experiencing adverse events. Paracetamol, opioid analgesics, antibiotics, muscle relaxants, and antidepressants should only be prescribed following a discussion between the treating clinician and the patient, considering the risks and possible benefits, and after or in conjunction with recommended nonpharmacological strategies for improving LBP. J Orthop Sports Phys Ther 2022;52(7):425-431. Epub: 18 May 2022. doi:10.2519/jospt.2022.10788.
Keywords: antibiotics; low back/lumbar spine; medications; pain; spinal stenosis.
Similar articles
-
Pharmacological treatments for low back pain in adults: an overview of Cochrane Reviews.Cochrane Database Syst Rev. 2023 Apr 4;4(4):CD013815. doi: 10.1002/14651858.CD013815.pub2. Cochrane Database Syst Rev. 2023. PMID: 37014979 Free PMC article. Review.
-
Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline.Ann Intern Med. 2007 Oct 2;147(7):505-14. doi: 10.7326/0003-4819-147-7-200710020-00008. Ann Intern Med. 2007. PMID: 17909211 Review.
-
Pharmacotherapy for Spine-Related Pain in Older Adults.Drugs Aging. 2022 Jul;39(7):523-550. doi: 10.1007/s40266-022-00946-x. Epub 2022 Jun 27. Drugs Aging. 2022. PMID: 35754070 Review.
-
Oral non-steroidal anti-inflammatory drugs versus other oral analgesic agents for acute soft tissue injury.Cochrane Database Syst Rev. 2020 Aug 12;8(8):CD007789. doi: 10.1002/14651858.CD007789.pub3. Cochrane Database Syst Rev. 2020. PMID: 32797734 Free PMC article.
-
Nonopioid pharmacological management of acute low back pain: A level I of evidence systematic review.J Orthop Res. 2023 Aug;41(8):1781-1791. doi: 10.1002/jor.25508. Epub 2023 Feb 22. J Orthop Res. 2023. PMID: 36811209
Cited by
-
Ultrasensitive functionalized CeO2/ZnO nanocomposite sensor for determination of a prohibited narcotic in sports pethidine hydrochloride.Heliyon. 2023 Apr 26;9(5):e15793. doi: 10.1016/j.heliyon.2023.e15793. eCollection 2023 May. Heliyon. 2023. PMID: 37180929 Free PMC article.
-
Identification of Responders to Balneotherapy among Adults over 60 Years of Age with Chronic Low Back Pain: A Pilot Study with Trajectory Model Analysis.Int J Environ Res Public Health. 2022 Nov 8;19(22):14669. doi: 10.3390/ijerph192214669. Int J Environ Res Public Health. 2022. PMID: 36429387 Free PMC article.
-
Pharmacological treatments for low back pain in adults: an overview of Cochrane Reviews.Cochrane Database Syst Rev. 2023 Apr 4;4(4):CD013815. doi: 10.1002/14651858.CD013815.pub2. Cochrane Database Syst Rev. 2023. PMID: 37014979 Free PMC article. Review.
-
Efficacy of stepped care treatment for chronic discogenic low back pain patients with Modic I and II changes.Interv Pain Med. 2023 Nov 15;2(4):100292. doi: 10.1016/j.inpm.2023.100292. eCollection 2023 Dec. Interv Pain Med. 2023. PMID: 39239218 Free PMC article.
-
The influence of cultural and religious factors on cross-national variations in the prevalence of chronic back and neck pain: an analysis of data from the global burden of disease 2019 study.Front Pain Res (Lausanne). 2023 May 25;4:1189432. doi: 10.3389/fpain.2023.1189432. eCollection 2023. Front Pain Res (Lausanne). 2023. PMID: 37305205 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous